Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
R-spondin 3 (RSPO3) is a secreted protein and member of the R-spondin family that acts as a positive regulator of Wnt signaling pathways. It plays a critical role in embryonic development, stem cell maintenance, angiogenesis, and tumorigenesis. RSPO3 enhances Wnt/β-catenin signaling by binding to LGR4/5/6 receptors on stem/progenitor cells and modulating co-receptors such as LRP6. It also promotes VEGF expression and regulates vascular stability. Its role in cancer is context-dependent, acting as an oncogene in some cases and a tumor suppressor in others.
Potentiates Wnt/β-catenin signaling by binding to LGR4/5/6 receptors and modulating co-receptors such as LRP6, competing with antagonists like DKK1 for binding to LRP6/Kremen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on R-spondin 3 (RSPO3).